CAS: 112108-01-7 - (-)-(6aS,13bR)-11-Chloro-12-hydroxy-7-methyl-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphtho[2,1-d]azepine
Fórmula:C19H21Cl2NO
InChI:InChI=1S/C19H20ClNO/c1-21-9-8-13-10-16(20)18(22)11-15(13)19-14-5-3-2-4-12(14)6-7-17(19)21/h2-5,10-11,17,19,22H,6-9H2,1H3/t17-,19+/m0/s1
Clave InChI:InChIKey=DMJWENQHWZZWDF-PKOBYXMFSA-N
SMILES:ClC=1C=C2C(=CC1O)C3C=4C=CC=CC4CCC3N(C)CC2
- Sinónimos:
- (6aS,13bR)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-benzo[d]naphth[2,1-b]azepin-12-ol
- (6aS,13bR)-11-chloro-7-methyl-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphtho[2,1-b]azepin-12-ol
- (6aS,13bR)-11-chloro-7-methyl-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphtho[2,1-b]azepin-12-ol hydrochloride (1:1)
- 5H-Benzo[d]naphth[2,1-b]azepin-12-ol, 11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-, (6aS,13bR)-
- 5H-Benzo[d]naphth[2,1-b]azepin-12-ol, 11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-, (6aS-trans)-
- Ecopipam
- Psyrx 101
- Sch-39166
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Ecopipam REF: 7W-GP0063CAS: 112108-01-7 | - - - | A consultar | Mar 07 Ene 25 | |
Ecopipam REF: TM-T31602CAS: 112108-01-7 | 98.5% | 183,00 €~1.295,00 € | Lun 24 Feb 25 | |
Ecopipam REF: 3D-FE159526CAS: 112108-01-7 | Min. 95% | 2.319,00 €~5.217,00 € | Lun 17 Mar 25 |
Ref: 7W-GP0063
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Ecopipam
CAS:112108-01-7
Ecopipam: orally active, selective dopamine D1/D5 antagonist (Ki: 1.2 nM/2.0 nM). 40x more selective over …
Fórmula:
C19H20ClNO
Pureza:
98.5%
Forma y color:
Solid
Peso molecular:
313.82
Ref: TM-T31602
1mg | 183,00 € | ||
2mg | 273,00 € | ||
5mg | 420,00 € | ||
10mg | 618,00 € | ||
25mg | 926,00 € | ||
50mg | 1.295,00 € |
Entrega estimada en Estados Unidos, el Lunes 24 de Febrero de 2025
Ecopipam
CAS:112108-01-7
Ecopipam is an antagonist drug that blocks the 5-HT2A receptor. It has been shown to …
Fórmula:
C19H20ClNO
Pureza:
Min. 95%
Peso molecular:
313.82 g/mol
Ref: 3D-FE159526
10mg | 2.319,00 € | ||
25mg | 3.478,00 € | ||
50mg | 5.217,00 € |
Entrega estimada en Estados Unidos, el Lunes 17 de Marzo de 2025